Adherence and quality of life in women with breast cancer being treated with oral hormone therapy.

Rebeca StahlschmidtAmanda Canato FerraciniCinthia Madeira de SouzaLuana Moreira de MedeirosCassia Raquel Teatin JuliatoPriscila Gava Mazzola

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2019)

A low percentage of women with breast cancer were highly adherent to HT treatment. Low/medium adherence was associated with higher stages of disease and systemic side effects. Quality of life had high scores, with better role function and less breast symptoms in women being treated with an AI.

Keyphrases

polycystic ovary syndrome
artificial intelligence
type diabetes
newly diagnosed
machine learning
mesenchymal stem cells
pregnant women
physical activity
skeletal muscle